Houshi Xu

机构：Shanghai Jiao Tong University, Fudan University, Shanghai Chest Hospital, Ohkawara Neurosurgical Hospital, Shanghai First People's Hospital, Shanghai Sunshine Rehabilitation Center, Shanghai Clinical Research Center, Huashan Hospital · ORCID：0000-0002-2878-0913

发表论文 54 篇 · 总被引 1240 次 · h-index 17

代表论文

• SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma (2022 · Frontiers in Immunology · 被引 28)
• Intranasal delivery of engineered extracellular vesicles promotes neurofunctional recovery in traumatic brain injury (2025 · Journal of Nanobiotechnology · 被引 25)
• Clinical Potential of Immunotherapies in Subarachnoid Hemorrhage Treatment: Mechanistic Dissection of Innate and Adaptive Immune Responses (2023 · Aging and Disease · 被引 23)
• Engineered extracellular vesicles for ischemic stroke: a systematic review and meta-analysis of preclinical studies (2023 · Journal of Nanobiotechnology · 被引 19)
• Single-cell RNA sequencing identifies a subtype of FN1 + tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy (2024 · Biomarker Research · 被引 18)
• Ventriculoperitoneal shunt for tuberculous meningitis-associated hydrocephalus: long-term outcomes and complications (2023 · BMC Infectious Diseases · 被引 10)